Bevacizumab and Endothelium Dependent Vasodilation

Clinical trial NCT01125943 · COMPLETED

Trial details

NCT number: NCT01125943
Sponsor: Radboud University Medical Center
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Hypertension Cancer Endothelial Dysfunction

Start date: 2010-06-01
Primary completion: 2011-10-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.